AptarGroup (ATR)
NYSEMaterialsMedical - Instruments & SuppliesSnapshot 2026-11-05
$144.04-1.92%
Close 2026-11-05 · 1-day change
NYSEMaterialsMedical - Instruments & SuppliesSnapshot 2026-11-05
QuarterlyIQ Insights · ATR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 33.1% |
| Our one-year growth estimate | diamond | 3.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the opposite direction.
Price observations: 365 days
Most sensitive to long-term interest rates.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 29.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 14 industry peers · Company calendar date is not available
ATR — CFO transition
Dated 2026-09-10
Chief Accounting Officer — Aditya J. Gandhi: The Chief Accounting Officer resigned to pursue another opportunity, but an interim successor was immediately appointed, indicating an orderly transition rather than a sudden loss of leadership.
Why it matters: Closures core sales grew 11% in Q3, while its margin fell 60 basis points. Higher input-cost pass-throughs helped sales but weighed on margin.
Watch forClosures core sales rise year over year. Its adjusted EBITDA margin rises above 15.5%.
Also watch forClosures core sales are flat or lower. Or its adjusted EBITDA margin falls below 15.5%.
Why it matters: Management set Q4 adjusted EPS guidance at $1.39 to $1.47. A result below that range would miss its stated target.
Worry ifQ4 2026 adjusted EPS is below $1.39.
Less concerning ifQ4 2026 adjusted EPS is $1.39 or higher.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$80 on $10,000 · ±0.8% | How much price usually moves either way. |
| Bad day | $228 loss on $10,000 · 2.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,318 loss on $10,000 · 23.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.